| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |